|
|||||
|
|
Novel fluorescence in situ hybridization‐based definition of bacille Calmette‐Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies |
|
| Authors: | Ashish M. Kamat Daniel L. Willis Rian J. Dickstein Rooselvelt Anderson Graciela Nogueras‐González Ruth L. Katz Xifeng Wu H. Barton Grossman Colin P. Dinney |
| Affiliation: | 1. Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA;3. Department of Cytopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA;4. Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| Abstract: | |
| Keywords: | bacille Calmette‐Gué rin bacille Calmette‐Gué rin failure bladder cancer clinical trials fluorescence in situ hybridization |